AI Verdict
AAPL has stronger fundamentals based on our AI analysis.
RVPH vs AAPL Fundamental Comparison
| Metric | RVPH | AAPL |
|---|---|---|
| Revenue | $122,867.0 | $143.8B |
| Net Income | $-19.9M | $42.1B |
| Net Margin | -16,167.8% | 29.3% |
| ROE | -229.7% | 47.7% |
| ROA | -124.8% | 11.1% |
| Current Ratio | 2.08x | 0.97x |
| Debt/Equity | 0.00x | 1.00x |
| EPS | N/A | $2.84 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RVPH vs AAPL: Frequently Asked Questions
Is RVPH or AAPL a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AAPL has stronger fundamentals. RVPH is rated STRONG SELL (90% confidence) while AAPL is rated BUY (87% confidence). This is not investment advice.
How does RVPH compare to AAPL fundamentally?
REVIVA PHARMACEUTICALS HOLDINGS, INC. has ROE of -229.7% vs Apple Inc.'s 47.7%. Net margins are -16,167.8% vs 29.3% respectively.
Which stock pays higher dividends, RVPH or AAPL?
RVPH has a dividend yield of N/A or no dividend while AAPL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RVPH or AAPL for long term?
For long-term investing, consider that RVPH has STRONG SELL rating with 90% confidence, while AAPL has BUY rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RVPH vs AAPL?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RVPH vs AAPL, the AI consensus favors AAPL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.